STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 70 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $62,000 | +51.2% | 5,841 | +48.6% | 0.00% | – |
| Q3 2019 | $41,000 | -21.2% | 3,932 | +16.6% | 0.00% | – |
| Q2 2019 | $52,000 | +1200.0% | 3,371 | +730.3% | 0.00% | – |
| Q4 2018 | $4,000 | +33.3% | 406 | +107.1% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 196 | 0.0% | 0.00% | – |
| Q2 2018 | $3,000 | -96.7% | 196 | -97.1% | 0.00% | – |
| Q4 2016 | $90,000 | +50.0% | 6,836 | +24.8% | 0.00% | – |
| Q3 2016 | $60,000 | +1400.0% | 5,478 | +2182.5% | 0.00% | – |
| Q2 2014 | $4,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |